This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Smith, P. J. Articles by Chew, S. L. Search for Related Content PubMed PubMed Citation Articles by Smith, P. J. Articles by Chew, S. L.

An Exonic Splicing Enhancer in Human IGF-I Pre-mRNA Mediates Recognition of Alternative Exon 5 by the Serine-Arginine Protein Splicing Factor-2/ Alternative Splicing Factor

Department of Endocrinology (P.J.S., E.L.S., R.J.M.R., S.L.C.), and Department of Anaesthesia and Intensive Care (J.C., C.J.H.), St. Bartholomew’s Hospital, Queen Mary, University of London, London EC1A 7BE, United Kingdom; and Cold Spring Harbor Laboratory (A.R.K.), Cold Spring Harbor, New York 11724

Address all correspondence and requests for reprints to: Shern L. Chew, Department of Endocrinology, St. Bartholomew’s Hospital, London EC1A 7BE, United Kingdom. E-mail: s.l.chew{at}mds.qmw.ac.uk

The human IGF-I gene has six exons, four of which are alternatively spliced. Variations in splicing involving exon 5 may occur, depending on the tissue type and hormonal environment. To study the regulation of splicing to IGF-I exon 5, we established an in vitro splicing assay, using a model pre-mRNA containing IGF-I exons 4 and 5 and part of the intervening intron. Using a series of deletion mutants, we identified an 18-nucleotide purine-rich splicing enhancer in exon 5 that increases the splicing efficiency of the upstream intron from 6 to 35%. We show that the serine-arginine protein splicing factor-2/alternative splicing factor specifically promotes splicing in cultured cells and in vitro and is recruited to the spliceosome in an enhancer-specific manner. Our findings are consistent with a role for splicing factor-2/alternative splicing factor in the regulation of splicing of IGF-I alternative exon 5 via a purine-rich exonic splicing enhancer.

This article has been cited by other articles:

				D. M. Mauger, C. Lin, and M. A. Garcia-Blanco hnRNP H and hnRNP F Complex with Fox2 To Silence Fibroblast Growth Factor Receptor 2 Exon IIIc Mol. Cell. Biol., September 1, 2008; 28(17): 5403 - 5419. [Abstract] [Full Text] [PDF]

				S. A. Akker, S. Misra, S. Aslam, E. L. Morgan, P. J. Smith, B. Khoo, and S. L. Chew Pre-Spliceosomal Binding of U1 Small Nuclear Ribonucleoprotein (RNP) and Heterogenous Nuclear RNP E1 Is Associated with Suppression of a Growth Hormone Receptor Pseudoexon Mol. Endocrinol., October 1, 2007; 21(10): 2529 - 2540. [Abstract] [Full Text] [PDF]

				L. M. Morimoto, P. A. Newcomb, E. White, J. Bigler, and J. D. Potter Variation in Plasma Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor Binding Protein-3: Genetic Factors Cancer Epidemiol. Biomarkers Prev., June 1, 2005; 14(6): 1394 - 1401. [Abstract] [Full Text] [PDF]

				N. A. Patel, H. S. Apostolatos, K. Mebert, C. E. Chalfant, J. E. Watson, T. S. Pillay, J. Sparks, and D. R. Cooper Insulin Regulates Protein Kinase C{beta}II Alternative Splicing in Multiple Target Tissues: Development of a Hormonally Responsive Heterologous Minigene Mol. Endocrinol., April 1, 2004; 18(4): 899 - 911. [Abstract] [Full Text] [PDF]

				N. Psilander, R. Damsgaard, and H. Pilegaard Resistance exercise alters MRF and IGF-I mRNA content in human skeletal muscle J Appl Physiol, September 1, 2003; 95(3): 1038 - 1044. [Abstract] [Full Text] [PDF]

				L. Cartegni, J. Wang, Z. Zhu, M. Q. Zhang, and A. R. Krainer ESEfinder: a web resource to identify exonic splicing enhancers Nucleic Acids Res., July 1, 2003; 31(13): 3568 - 3571. [Abstract] [Full Text] [PDF]

				V. van Heyningen and K. A. Williamson PAX6 in sensory development Hum. Mol. Genet., May 15, 2002; 11(10): 1161 - 1167. [Abstract] [Full Text] [PDF]